CVNA insider plans Rule 144 stock sale

For issuer CVNA, James Danforth Quayle filed a notice of intent to sell common stock under Rule 144.

Rhea-AI Filing Summary

For issuer CVNA, James Danforth Quayle filed a notice of intent to sell common stock under Rule 144. The filing lists 14,525 shares of common stock to be sold on or about 08/14/2026, in connection with an Exercise of Stock Options, for cash. The listed aggregate market value for these securities is $1,070,492.50, and the shares are traded on the NYSE. The notice also reports that, during the past three months, a 10b5‑1 plan sale of 14,525 shares occurred on 06/10/2026 for total proceeds of $1,016,750.00.

Key Figures

Shares to be sold: 14,525 shares Aggregate market value of planned sale: $1,070,492.50 Shares sold in past 3 months: 14,525 shares +2 more

5 metrics

Shares to be sold 14,525 shares Common stock proposed for sale around 08/14/2026 under Rule 144

Aggregate market value of planned sale $1,070,492.50 Listed value for 14,525 common shares to be sold on 08/14/2026

Shares sold in past 3 months 14,525 shares 10b5-1 sale on 06/10/2026 reported in the past three months

Proceeds from 06/10/2026 sale $1,016,750.00 Total proceeds from 10b5-1 sale of 14,525 shares on 06/10/2026

Planned sale date 08/14/2026 Date associated with securities to be sold and option exercise

Key Terms

Rule 144, 10b5-1, Exercise of Stock Options, Executive Financial Services

4 terms

Rule 144 regulatory

"144: Securities Information Common | Morgan Stanley Smith Barney LLC"

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

10b5-1 regulatory

"10b5-1 Sales for JAMES DANFORTH QUAYLE 300 E. Rio Salado"

A 10b5-1 plan is a pre-set schedule that lets company insiders buy or sell shares according to written instructions made when they do not possess material, nonpublic information. Think of it as a timed automatic payment for stock trades: it helps insiders avoid accusations of trading on secret information and gives outside investors a clearer signal about whether sales are routine or potentially informative about the company’s prospects.

Exercise of Stock Options financial

"Common | 08/14/2026 | Exercise of Stock Options | Issuer"

Executive Financial Services financial

"Common | Morgan Stanley Smith Barney LLC Executive Financial Services"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What stock sale is James Danforth Quayle planning for CVNA under Rule 144?

James Danforth Quayle plans a Rule 144 sale of 14,525 shares of CVNA common stock around 08/14/2026, tied to an Exercise of Stock Options for cash, with an indicated aggregate market value of $1,070,492.50.

How many CVNA shares did James Danforth Quayle sell in the last 3 months?

Over the past three months, James Danforth Quayle reported selling 14,525 shares of CVNA common stock on 06/10/2026 under a 10b5-1 plan, for total reported proceeds of $1,016,750.00.

What is the reported market value of the CVNA shares to be sold under this notice?

The Rule 144 notice lists an aggregate market value of $1,070,492.50 for the 14,525 shares of CVNA common stock proposed to be sold, which are traded on the NYSE as of 08/14/2026.

What is the source of the CVNA shares James Danforth Quayle plans to sell?

The CVNA shares are associated with an Exercise of Stock Options. The filing states that 14,525 shares of common stock are to be sold for cash in connection with that option exercise, with a planned date of 08/14/2026.

Is the recent CVNA stock activity by James Danforth Quayle under a trading plan?

Yes. The filing notes that the 06/10/2026 sale of 14,525 shares of CVNA common stock for $1,016,750.00 was conducted as 10b5-1 Sales, indicating use of a pre‑arranged trading plan.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 08/14/2026 - 04:33 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001210412
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	CARVANA CO
SEC File Number	001-38073
Address of Issuer	300 E. Rio Salado Parkway Tempe ARIZONA 85281
Phone	6029229866
Name of Person for Whose Account the Securities are To Be Sold	JAMES DANFORTH QUAYLE
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	14525	1070492.50	719916415	08/14/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/14/2026	Exercise of Stock Options	Issuer			14525	08/14/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for JAMES DANFORTH QUAYLE 300 E. Rio Salado Parkway Tempe AZ 85281	Common	06/10/2026	14525	1016750.00

144: Remarks and Signature

Remarks
Date of Notice	08/14/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	03/11/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ James Danforth Quayle
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)